Prevalence of gyrA, gyrB, parC, and parE Mutations in Clinical Isolates of Streptococcus pneumoniae with Decreased Susceptibilities to Different Fluoroquinolones and Originating from Worldwide Surveillance Studies during the 1997-1998 Respiratory Season

From 8,419 worldwide clinical isolates of Streptococcus pneumoniae obtained during 1997-1998, 69 isolates with reduced susceptibility or resistance to fluoroquinolones (FQs) were molecularly characterized. For the isolates in this prevalence study, only parC (Ser-79→Tyr) and gyrA (Ser-81→Phe or Tyr)...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

I whakaputaina i:	Antimicrob Agents Chemother
Ngā kaituhi matua:	Jones, Mark E., Sahm, Daniel F., Martin, Nele, Scheuring, Sibylle, Heisig, Peter, Thornsberry, Clyde, Köhrer, Karl, Schmitz, Franz-Josef
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	American Society for Microbiology (ASM) 2000
Ngā marau:	Mechanisms of Resistance
Urunga tuihono:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89708/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10639387/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.2.462-466.2000
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!